Results 1 to 10 of about 2,359,169 (353)

Secukinumab in the treatment of psoriasis: patient selection and perspectives [PDF]

open access: yesPsoriasis: Targets and Therapy, 2018
Eric J Yang,1,2 Kristen M Beck,1 Wilson Liao1 1Department of Dermatology, University of California San Francisco, San Francisco, CA, USA; 2Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA Abstract ...
Yang EJ, Beck KM, Liao W
doaj   +3 more sources

Long-acting growth hormones: innovations in treatment and guidance on patient selection in pediatric growth hormone deficiency [PDF]

open access: yesAnnals of Pediatric Endocrinology & Metabolism
Long-acting growth hormones (LAGHs) represent a significant advancement in the treatment of pediatric GH deficiency, offering an alternative to daily recombinant human GH (rhGH) therapy.
Chiara Rodaro   +3 more
doaj   +2 more sources

Waiting lists and patient selection [PDF]

open access: yes, 2006
We develop a model of waiting lists for public hospitals when physicians deliver both private and public treatment. Public treatment is free but rationed, i.e., only cases meeting some medical criteria area admitted for treatment. Private treatment has no waiting time but entails payment of a fee.
Barros, Pedro Pita   +3 more
openaire   +4 more sources

A single-center long-term experience of active surveillance for prostate cancer: 15 years of follow-up [PDF]

open access: yesInvestigative and Clinical Urology, 2021
Purpose: To describe a single-center 15-year experience of active surveillance (AS) for prostate cancer (PCa). Materials and Methods: We retrospectively reviewed patients who underwent AS between 2003 and 2018.
Sang Hun Song   +5 more
doaj   +1 more source

Navigate Towards the Immunotherapy Era: Value of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer Patients With Brain Metastases

open access: yesFrontiers in Immunology, 2022
Brain metastases (BMs) in non-small-cell lung cancer (NSCLC) patients are associated with significant morbidity and poor prognosis. Immune checkpoint inhibitors (ICIs) have resulted in a paradigm shift in the management of advanced NSCLC.
Guanqun Yang   +5 more
doaj   +1 more source

Influence of pre-stroke dependency on safety and efficacy of endovascular therapy: A systematic review and meta-analysis

open access: yesFrontiers in Neurology, 2022
Background and purposeIn the landmark trials studying endovascular thrombectomy (EVT), pre-stroke dependent (PSD) patients were generally excluded. This systematic review and meta-analysis aimed to compare the safety and efficacy of EVT between PSD and ...
Hengxiao Zhao   +22 more
doaj   +1 more source

Invasive Hemodynamic Assessment and Procedural Success of Transcatheter Tricuspid Valve Repair—Important Factors for Right Ventricular Remodeling and Outcome

open access: yesFrontiers in Cardiovascular Medicine, 2022
IntroductionSevere tricuspid regurgitation (TR) is a common condition promoting right heart failure and is associated with a poor long-term prognosis.
Varius Dannenberg   +19 more
doaj   +1 more source

Role of plaque inflammation in symptomatic carotid stenosis

open access: yesFrontiers in Neurology, 2023
ObjectivePrior studies have shown that plaque inflammation on FDG-PET and the symptomatic carotid atheroma inflammation lumen-stenosis (SCAIL) score were associated with recurrent ischemic events, but the findings have thus far not been widely validated.
Yilong Zheng   +22 more
doaj   +1 more source

Predicting Residual Angina After Chronic Total Occlusion Percutaneous Coronary Intervention: Insights from the OPEN‐CTO Registry

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Given that percutaneous coronary intervention (PCI) of a chronic total occlusion (CTO) is indicated primarily for symptom relief, identifying patients most likely to benefit is critically important for patient selection and shared decision ...
Neel M. Butala   +14 more
doaj   +1 more source

Left Ventricular Assist Device as a Destination Therapy: Current Situation and the Importance of Patient Selection

open access: yesLife, 2023
Advanced heart failure is a growing problem for which the best treatment is cardiac transplantation. However, the shortage of donors’ hearts made left ventricular assist devices as destination therapy (DT-LVAD) a highly recommended alternative: they ...
María Melendo-Viu   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy